Cargando…

Low doses of dasiglucagon consistently increase plasma glucose levels from hypoglycaemia and euglycaemia in people with type 1 diabetes mellitus

AIM: To characterize the pharmacokinetic and pharmacodynamic properties of dasiglucagon, a novel, stable and liquid formulated glucagon analogue, during hypoglycaemic and euglycaemic conditions in adult patients with type 1 diabetes mellitus. RESEARCH DESIGN AND METHODS: In this randomized double‐bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hövelmann, Ulrike, Olsen, Minna Brændholt, Mouritzen, Ulrik, Lamers, Daniela, Kronshage, Birgit, Heise, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587565/ https://www.ncbi.nlm.nih.gov/pubmed/30350477 http://dx.doi.org/10.1111/dom.13562

Ejemplares similares

Deceptive Late Maternal Euglycaemia
por: Irene, Arockia Silviya, et al.
Publicado: (2021)

Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial
por: Pieber, Thomas R., et al.
Publicado: (2021)

Management of lercanidipine overdose with hyperinsulinaemic euglycaemia therapy: case report
por: Hadjipavlou, George, et al.
Publicado: (2011)

Severe Diltiazem Poisoning Treated with Hyperinsulinaemia-Euglycaemia and Lipid Emulsion
por: Monteiro, Nadine, et al.
Publicado: (2013)

Dasiglucagon for the Treatment of Insulin-induced Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Meta-analysis
por: Maji, Shampa, et al.
Publicado: (2023)

Bench-to-bedside review: Hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers
por: Lheureux, Philippe ER, et al.
Publicado: (2006)

Evaluating Ease of Use and Patient Safety of Dasiglucagon Hypo Pal Autoinjector for the Management of Hypoglycemia
por: Schaumleffel, Carol
Publicado: (2023)

Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model
por: Hinahara, Jordan, et al.
Publicado: (2022)

A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
por: Heise, Tim, et al.
Publicado: (2016)

A mouse model of gestational diabetes shows dysregulated lipid metabolism post-weaning, after return to euglycaemia
por: Furse, Samuel, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
por: Heise, Tim, et al.
Publicado: (2016)

Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy
por: Heise, Tim, et al.
Publicado: (2009)

Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study
por: Tehranchi, Ramin, et al.
Publicado: (2022)

Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial
por: Laugesen, Christian, et al.
Publicado: (2023)

Continuous glucose monitoring for children with hypoglycaemia: Evidence in 2023
por: Worth, Chris, et al.
Publicado: (2023)

A Comparative Study of Dasiglucagon Ready-to-Use Autoinjector and Glucagon Emergency Kit During Rescue from Simulated Severe Hypoglycemia
por: Bailey, Naila Celeste, et al.
Publicado: (2022)

Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study
por: Suico, Jeffrey G., et al.
Publicado: (2020)

Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
por: Kristensen, Peter L, et al.
Publicado: (2016)

Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions
por: Hövelmann, Ulrike, et al.
Publicado: (2017)

Hypoglycæmia
Publicado: (1934)

Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial
por: Moser, Othmar, et al.
Publicado: (2018)

A Randomized Controlled Clinical Trial in Healthy Older Adults to Determine Efficacy of Glycine and N-Acetylcysteine Supplementation on Glutathione Redox Status and Oxidative Damage
por: Lizzo, Giulia, et al.
Publicado: (2022)

Development and validation of the hypoglycaemia problem-solving scale for people with diabetes mellitus
por: Wu, Fei-Ling, et al.
Publicado: (2016)

Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
por: Pavlou, Panagiotis, et al.
Publicado: (2021)

Insulin Hypoglycæmia
Publicado: (1948)

The consequences of hypoglycaemia
por: Amiel, Stephanie A.
Publicado: (2021)

Early hypoglycaemia and hyperglycaemia and 'tight' glycaemic control with and without glucose infusions
por: Raobaikady, R, et al.
Publicado: (2004)

Use of flash glucose monitoring for post-bariatric hypoglycaemia diagnosis and management
por: Lobato, Carolina B., et al.
Publicado: (2020)

Should continuous glucose monitoring be used to manage neonates at risk of hypoglycaemia?
por: Kalogeropoulou, Maria-Sofia, et al.
Publicado: (2023)

Hyperinsulinaemic hypoglycaemia in non-anaesthetized Göttingen minipigs induces a counter-regulatory endocrine response and electrocardiographic changes
por: Lyhne, Mille K., et al.
Publicado: (2021)

Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes
por: Magri, Caroline Jane, et al.
Publicado: (2018)

SUN-299 Flash Glucose Sensor Monitoring for Patients with Endogenous Hyperinsulinaemic Hypoglycaemia
por: Arshad, Muhammad Fahad, et al.
Publicado: (2020)

Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
por: Castellanos, Luz E., et al.
Publicado: (2021)

Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia
por: Vickneson, Keeran, et al.
Publicado: (2021)

Hypoglycaemia in adrenal insufficiency
por: Lee, Shien Chen, et al.
Publicado: (2023)

Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations
por: Kapoor, R. R., et al.
Publicado: (2011)

Research: Adolescents with Type 1 diabetes mellitus experience psychosensorial symptoms during hypoglycaemia
por: Law, J R, et al.
Publicado: (2014)

Transient Neonatal Diabetes Mellitus followed by recurrent asymptomatic hypoglycaemia: a case report
por: Priyadarshi, Archana, et al.
Publicado: (2015)

Reactive hypoglycaemia during the OGTT after gestational diabetes mellitus: Metabolic implications and evolution
por: Quansah, Dan Yedu, et al.
Publicado: (2022)

Non-invasive and minimally invasive glucose monitoring devices: a systematic review and meta-analysis on diagnostic accuracy of hypoglycaemia detection
por: Lindner, Nicole, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j5lgr5g7fh8ffcgh4adl190hcc